Brief: Xilio Therapeutics Q1 Net Income USD -13.265 Million
08/05/2025 12:30
May 08 (Reuters) - Xilio Therapeutics Q1 operating expenses USD 16.781 million. Q1 income from operations USD -13.851 million Q1 basic EPS USD -0.18
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla